Alternate Title: CDC: 3-Quinuclidinyl Benzilate
This webpage is maintained by the Centers for Disease Control and Prevention (CDC). The webpage provides information and resources on BZ (3-Quinuclidinyl Benzilate). "BZ toxicity, which might occur by inhalation, ingestion, or skin absorption, is an anticholinergic syndrome consisting of a combination of signs and symptoms that might include hallucinations; agitation; mydriasis (dilated pupils); blurred vision; dry, flushed skin; urinary retention; ileus; tachycardia; hypertension; and elevated temperature (>101ºF). The onset of incapacitation is dose-dependent. It might occur as early as 1 hour after exposure and continue up to 48 hours (1)."
Centers for Disease Control and Prevention: http://www.cdc.gov/